Summary of Disaggregation of Product Revenues from Contracts with Customers by Major Product Line (Detail) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2021		Dec. 31, 2020		Dec. 31, 2019
Disaggregation of Revenue [Line Items]
Revenue	$ 670,534		$ 366,260		$ 270,245
Product Revenue
Disaggregation of Revenue [Line Items]
Revenue	670,319	[1]	366,136	[2]	270,097	[3]
Royalty and Other Income
Disaggregation of Revenue [Line Items]
Revenue	$ 215		$ 124		$ 148

[1] 2021 revenue for filtration products includes revenue related to Polymem from July 1, 2021 as well as BioFlex and NTM from December 16, 2021 through December 31, 2021. 2021 revenue for proteins products includes revenue related to Avitide from September 20, 2021 through December 31, 2021.

[2] 2020 revenue for filtration products includes revenue related to EMT from July 13, 2020, NMS from October 20, 2020 and ARTeSYN from December 3, 2020 through December 31, 2020.

[3] 2019 revenue includes process analytics revenue related to C Technologies from June 1, 2019 through December 31, 2019.